<DOC>
	<DOCNO>NCT00707434</DOCNO>
	<brief_summary>The goal clinical research study learn The Guardian® blood-sugar monitoring device use reliably patient high blood sugar receive care ICU . Researchers compare blood-sugar measurement study device blood-sugar measurement standard `` fingerstick '' method blood-sugar testing . This do see new device accurately measure blood sugar .</brief_summary>
	<brief_title>Continuous Glucose Monitoring Critically Ill</brief_title>
	<detailed_description>The Study Device : The Guardian® blood-sugar monitoring device design automatically record blood sugar level many time per hour , without require multiple fingersticks . It use blood sugar `` sensor '' ( electronic measuring device ) size beeper . The sensor attach small catheter small needle . Once catheter inserted skin , needle remove right away . Use Study Device : If agree take part study , ICU , catheter needle part study device insert skin abdomen thigh . The device automatically measure blood sugar every 10 second data review research staff . The needle remove right away . The catheter must change every 3 day ( +/- 3 day ) research staff . You study device place 15 day ( leave ICU , whichever come first ) . Standard Monitoring Blood Sugar Levels : While study , blood sugar also monitor accord standard care . This form blood sugar check use small needle prick tip finger every hour , necessary . The blood sugar measurement study device use way affect decision blood sugar monitoring care . Length Study Participation : After study device remove body last time ( 15 day leave ICU ) , consider study . If intolerable side effect occur , infection occur seem cause study device , take study early . This investigational study . The study device commercially available FDA approve monitor blood sugar level outpatient ( outside hospital ) use . Using device patient hospital consider experimental . At time , use way research . Up 60 patient take part multicenter study . Up 25 enrol M. D. Anderson .</detailed_description>
	<criteria>1 . Patients University Texas collaborative intensive care unit . 2 . Critically ill patient insulin infusion protocol 1 . Patients legal representative consent 2 . Patients large area skin affect allow implantation device . 3 . Patients &lt; 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Continuous Glucose Monitor</keyword>
	<keyword>Medtronic Guardian</keyword>
	<keyword>Guardian® blood-sugar monitoring device</keyword>
	<keyword>Glucose Monitoring</keyword>
	<keyword>Critically Ill</keyword>
	<keyword>ICU</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Glycemic Excursions</keyword>
	<keyword>Glucose Control</keyword>
	<keyword>Glucose Testing</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Insulin Infusion</keyword>
</DOC>